Viewing Study NCT02694133


Ignite Creation Date: 2025-12-25 @ 2:42 AM
Ignite Modification Date: 2026-03-04 @ 10:12 PM
Study NCT ID: NCT02694133
Status: COMPLETED
Last Update Posted: 2016-02-29
First Post: 2011-12-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Telerehabilitation in the Patients With Aphasia
Sponsor: Kaohsiung Veterans General Hospital.
Organization:

Study Overview

Official Title: Efficacy of Telerehabilitation in the Patients With Aphasia
Status: COMPLETED
Status Verified Date: 2016-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The study will invite 30 patients to join, and they will be arranged in the face to face group and telerehabilitation group randomly.

In the telerehabilitation group, the investigators use the mobile device, which with the camera and speaker, for patients to practice the naming training at home, and assess the speech ability every 2-4weeks by speech therapist via telerehabilitation platform.

Concise Chinese Aphasia Test (CCAT) and ASHA FACS conceptual framework Test will be used as the assessment tool for evaluation speech ability and functional ability.

The investigators expect that patients can improve their speech ability, functional ability, and quality of life via telerehabilitation speech therapy.

And the investigators can establish the standard telerehabilitation speech therapy protocol for aphasia therapy.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: